Basic virology

A promising Ebolavirus antiviral compound

A small molecule antiviral compound has been shown to protect rhesus monkeys against lethal Ebolavirus disease, even when given up to three days after virus inoculation. The compound, called GS-5734, is a nucleoside analog. After uptake into cells, GS-5734 is converted to a nucleoside triphosphate (illustrated, bottom panel) which is incorporated by the viral RNA dependent RNA …

A promising Ebolavirus antiviral compound Read More »

Person to person Zika virus transmission

The title of a Eurosurveillance article, “An autochthonous case of Zika due to possible sexual transmission, Florence, Italy, 2014” was written to make the headlines. The title should be “An autochthonous case of Zika due to person to person contact, Florence, Italy, 2014.” An Italian man returns from a 10 day holiday in Thailand and a day later develops a …

Person to person Zika virus transmission Read More »

Zika virus and the fetus

An epidemic of Zika virus infection began in Brazil in April 2015, and six months later there was a surge in the number of infants born with microcephaly. Confirming that Zika virus causes microcephaly will require much more information than is currently available. So far there have been few isolations of Zika virus RNA from microcephalic fetuses or amniotic fluid. …

Zika virus and the fetus Read More »

Rubella virus and birth defects

Amidst the fear surrounding Zika virus, remember that there are over 100,000 children born each year with birth defects caused by infection with rubella virus. The virus Rubella virus is a member of the Togaviridae family, which also includes chikungunya virus. The genome is a 9.7 kilobase, positive strand RNA enclosed in a capsid and surrounded by a membrane …

Rubella virus and birth defects Read More »

Scientists, share your Zika virus reagents!

Today I learned that a number of investigators refuse to share their samples of Zika virus with other laboratories. There are countless stories about scientists not sharing reagents because they want to be the first to make a discovery. This behavior allows them to publish first, secure more grant funding, garner invitations to speak at meetings, and generally stroke their egos. This …

Scientists, share your Zika virus reagents! Read More »

Scroll to Top